Mangalam Drugs completes expansion work at Vapi plant

24 Aug 2016 Evaluate

Mangalam Drugs & Organics, one of the leading Pharma/API Company has successfully completed the expansion/ modernization work of its Plant on Unit-2 situated at Vapi. The company has also commenced the trial operations at this newly expanded Unit-2 situated at Vapi on  August 22, 2016. The company also takes pride in announcing that it has completed this project in record time. The total cost of the expansion is around Rs 30 crore.

The plant will produce the API's for Malaria and ARV's. The company will be filing DMF's for all its product with WHO Geneva. It also plans to file DMF's of certain API's with USFDA in the due course of time.

Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

Mangalam Drugs&Org. Share Price

25.34 0.01 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×